DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced the peer-reviewed ...
Atrial fibrillation (irregular heartbeat), which causes poor blood flow, is another cardiovascular condition that can cause ...
Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...
Microglia play a crucial role in neuroinflammation after ischemic brain injury. Previous data have shown that leukocyte immunoglobulin-like receptor B4 (LILRB4) was upregulated in mice after middle ...
LOS ANGELES -- For patients with large vessel occlusion (LVO) strokes, researchers found ways to make adjunctive ...
Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...
15don MSN
Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of stroke; however, it did not lessen disability more than best medical ...
In patients with high comorbidity burden that receive EVT for MCA medium-vessel occlusion there are worse clinical outcomes.
1–7 However, they focused on anterior LVO involving the internal carotid artery and proximal middle cerebral artery (MCA). The HERMES collaboration, a meta-analysis of five RCTs (MR CLEAN, ESCAPE, ...
In this study, we used Adeno-associated vectors carrying Netrin-1 gene (AAV-NT-1) to up-regulate the expression level of Netrin-1 in rats’ brain after middle cerebral artery occlusion (MCAO). We found ...
Off-label in-silico flow diverter performance assessment in posterior communicating artery aneurysms
32 We then performed a series of additional pre-processing steps on the segmented masks, and on the surface meshes provided in the AneuX database, to acquire surface meshes for the internal carotid ...
This evidence implicates TRPM2 in a broad range of pathways that take place every stage of cerebral ischemic injury, thus making TRPM2 a promising target for drug development for stroke and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results